Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.

Clinical lymphoma, myeloma & leukemia - 1 May 2023

Tinsley-Vance Sara M, Ali Najla Al, Ball Somedeb, Aguirre Luis E, Jain Akriti G, Hussaini Mohammad Omar, Chan Onyee, Kuykendall Andrew, Sweet Kendra, Lancet Jeffrey, Padron Eric, Sallman David A, Komrokji Rami S

Abstract excerpt

Introduction/Background The impact of biological sex on the clinical phenotype, genotype, and outcomes among patients with MDS is not well characterized. Materials and Methods We retrospectively reviewed the clinical and genomic data from male and female patients included in our institutional MDS database at Moffitt Cancer Center. Results Among 4580 patients with MDS, 2922 (66%) were men and 1658 (34%) were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma Diagnosis and Treatment

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Phenotype

Share to Prognosis

Share to Splicing Factor U2AF

Source

Open in PubMed Open full text

Identifiers

PMID: 36813626
DOI: 10.1016/j.clml.2023.01.007
PMCID: PMC10121764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.PMID 36813626Read ↗

Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Semantic proximity Read ↗

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.Semantic proximity Read ↗

Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology.Semantic proximity Read ↗

A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study.Semantic proximity Read ↗

Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.Semantic proximity Read ↗

Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.Semantic proximity Read ↗

Sex Differences in the Spectrum of Clonal HematopoiesisSemantic proximity Read ↗

Treatment-related myelodysplastic syndrome: molecular characteristics and therapy.Semantic proximity Read ↗

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).Semantic proximity Read ↗

Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation.Semantic proximity Read ↗

Prognostic Significance of<i>ASXL1</i>Mutations in Patients With Myelodysplastic SyndromesSemantic proximity Read ↗

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.